Spanish gene editing biotech licenses DNA-cutting enzymes from Caszyme for up to $43M
Spanish gene editing biotech licenses DNA-cutting enzymes from Caszyme for up to $43M dincorvaia Mon, 11/04/2024 - 13:48
Mon Nov 4, 2024 22:06
Swiss biotech inks reverse merger with GI-focused Renexxion
Swiss biotech inks reverse merger with GI-focused Renexxion gmasson Mon, 11/04/2024 - 13:35
Mon Nov 4, 2024 21:06
BigHat unveils next-gen ADC designed with Lonza’s Synaffix as lead program
BigHat unveils next-gen ADC designed with Lonza’s Synaffix as lead program gmasson Mon, 11/04/2024 - 10:50
Mon Nov 4, 2024 19:03
The Column Group's biotech taps Surrozen for lung disease research pact
The Column Group's biotech taps Surrozen for lung disease research pact dincorvaia Mon, 11/04/2024 - 10:49
Mon Nov 4, 2024 19:03
AstraZeneca talks up potential for obesity combo treatments, insists it's 'playing to win' in crowded field
AstraZeneca talks up potential for obesity combo treatments, insists it's 'playing to win' in crowded field jwaldron Mon, 11/04/2024 - 10:43
Mon Nov 4, 2024 19:03
Boston Scientific bolsters pulsed field ablation business with Cortex buy
Boston Scientific bolsters pulsed field ablation business with Cortex buy chale Mon, 11/04/2024 - 10:38
Mon Nov 4, 2024 19:03